O

OrbiMed Portfolio holdings

AUM $3.98B
1-Year Est. Return 13.05%
This Quarter Est. Return
1 Year Est. Return
+13.05%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$5.91B
AUM Growth
-$1.07B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
169
New
Increased
Reduced
Closed

Top Buys

1
+$139M
2
+$132M
3
+$110M
4
PFE icon
Pfizer
PFE
+$98.3M
5
GILD icon
Gilead Sciences
GILD
+$85.6M

Top Sells

1
+$372M
2
+$99.8M
3
+$98.1M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$93.8M
5
TNDM icon
Tandem Diabetes Care
TNDM
+$68M

Sector Composition

1 Healthcare 97.58%
2 Financials 1.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
51
$31.2M 0.52%
928,189
+759,568
52
$31.1M 0.52%
2,902,239
53
$31M 0.52%
200,467
+61,856
54
$30M 0.5%
2,039,282
55
$28.7M 0.48%
+1,192,400
56
$28.3M 0.48%
244,641
57
$25.3M 0.43%
+1,380,160
58
$25.2M 0.42%
3,409,865
59
$23.7M 0.4%
3,027,542
60
$23.4M 0.39%
551,200
-215,178
61
$23.1M 0.39%
257,549
+150,049
62
$21.6M 0.36%
+962,900
63
$21.3M 0.36%
105,200
-16,900
64
$20.9M 0.35%
347,000
-1,000,000
65
$20.7M 0.35%
+582,302
66
$19.9M 0.33%
660,000
67
$19.4M 0.33%
1,336,547
-1,008,900
68
$18.9M 0.32%
175,000
69
$18.9M 0.32%
1,662,812
+1,028,000
70
$17.9M 0.3%
351,380
71
$17.4M 0.29%
+229,000
72
$17.2M 0.29%
2,839,500
73
$16.5M 0.28%
+1,381,300
74
$16.2M 0.27%
231,349
75
$16.2M 0.27%
147,973
1 2
3
4 5